ROYAL BANK OF CANADA - HISTOGENICS CORP ownership

HISTOGENICS CORP's ticker is HSGX and the CUSIP is 43358V109. A total of 31 filers reported holding HISTOGENICS CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of HISTOGENICS CORP
ValueSharesWeighting
Q2 2019$02,508
-1.4%
0.00%
Q1 2019$02,5430.0%0.00%
Q4 2018$0
-100.0%
2,5430.0%0.00%
Q3 2018$1,000
-83.3%
2,543
+1.7%
0.00%
Q2 2018$6,0002,500
+27677.8%
0.00%
Q4 2017$090.0%0.00%
Q3 2017$09
-85.2%
0.00%
Q4 2016$0610.0%0.00%
Q3 2016$0610.0%0.00%
Q2 2016$0610.00%
Other shareholders
HISTOGENICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
S Squared Technology, LLC 1,169,387$2,923,0002.32%
Abingworth LLP 888,889$2,204,0001.26%
Sofinnova Investments, Inc. 4,154,080$10,386,0000.66%
Third Security, LLC 2,690,570$6,726,0000.54%
Archon Capital Management LLC 293,090$733,0000.23%
Perceptive Advisors 2,203,277$5,508,0000.14%
Endurant Capital Management LP 56,177$140,0000.06%
Sio Capital Management, LLC 39,175$98,0000.05%
Palo Alto Investors LP 302,922$757,0000.03%
Rossmore Private Capital 11,236$28,0000.02%
View complete list of HISTOGENICS CORP shareholders